{
  "claim_id": "claim_001",
  "claim": "Flublok contains 3x the hemagglutinin (HA) antigen content of standard-dose flu vaccines, which has been linked to greater immunogenicity vs standard-dose flu vaccines.",
  "document": {
    "pdf_name": "Grohskopf_et_al.__2023_"
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2
  },
  "extracted_evidence": [
    {
      "id": "comp_1",
      "quote": "A 0.5-mL dose contains 45 \u00b5g of HA derived from each vaccine virus (180 \u00b5g total).",
      "relevance_explanation": "This quote specifies that Flublok (RIV4) contains 45 \u00b5g of hemagglutinin (HA) per virus, which is three times the 15 \u00b5g per virus found in standard-dose flu vaccines, directly supporting the claim about antigen content.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    },
    {
      "id": "comp_2",
      "quote": "Standard dose, nonadjuvanted IIV4 s contain 15 \u00b5g of HA per vaccine virus in a 0.5-mL dose (7.5 \u00b5g of HA per vaccine virus in a 0.25-mL dose).",
      "relevance_explanation": "This quote establishes the HA content of standard-dose flu vaccines, providing a direct comparison to the higher HA content in Flublok, supporting the claim of a 3x difference.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ]
}